Logos Global Management LP Essa Pharma Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $5.35 Million - $12.5 Million	-865,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $1.05 Million - $1.94 Million	-135,000 Reduced 13.5%	865,000 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $7.76 Million - $29.4 Million	1,000,000 New	1,000,000 $8 Million
Q1 2021 May 17, 2021	SELL	$11.61 - $32.08 $6.39 Million - $17.6 Million	-550,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $3.01 Million - $6.66 Million	550,000 New	550,000 $6.56 Million

35.2M

37.7K

3.8K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $286M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.